(*) EU Approval Date: 2021. 01.25
(*) USA Approval Date: 2022. 04.29
AS: Ankylosing Spondylitis
Company
Generic Name: Upadacitinib
JAK: JAnus Kinase
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 14
Patent>UpDate: 2022. 06.28
RTM
RTM Web-Site